Hiperalfalipoproteinemia: uma revisão de literatura

Detalhes bibliográficos
Autor(a) principal: Rodrigues, Paula Rayssa
Data de Publicação: 2022
Outros Autores: Martins, Lucas, Silvério, Alessandra Cristina Pupin
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/37461
Resumo: Objective: To analyze and address the causes and alterations related to hyperalphalipoproteinemia, comparing the general patterns of the population. Methodology: An Integrative Literature Review was conducted, in which key words specified in the Pubmed and Science Direct databases were used: "hyperalphalipoprotenemia" OUR "hyperalphalipoprotein" OUR "HDLc". Results: Mutations in individuals with hyperalphalipoproteinemia, single nucleotide polymorphisms, deleterious genes, cetp gene, hepatic SR-BI, endothelial lipase (EL) gene, splicing defect, genes and proteins ANGPTL3 and ANGPTL8 can be highlighted. In addition, changes in surface fluidity and HDLc membrane constituents were noted, changes in the RCT process and in the ability to increase expression and to activate endothelial synthesis of nitric oxide (NO). Furthermore, changes caused by CETP deficiency cannot be related to a cardioprotective, antiatherogenic and anti-inflammatory effect, and even a U-shaped relationship between plasma HDLc and ischemic electrocardiographic changes, where CETP deficiency accumulates. Moreover, the presence of the P376L variant, intervenenegatively in the processing of SR-BI. Finally, individuals with higher HDLc levels exhibit cholesterol particles enriched by apolipoproteins, which cause changes to the anti-inflammatory action of HDL itself. Conclusion: Changes in the physiological functioning of HDLc, which cause hyperalphalipoproteinemia, are caused by several mutations that lead to changes in the membrane mechanism, CETP, SR-BI and inflammatory processes. More research is needed to conclude about the cardioprotective effect.
id UNIFEI_ee5043c2ab1cbc19054cb4ef868e5a76
oai_identifier_str oai:ojs.pkp.sfu.ca:article/37461
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Hiperalfalipoproteinemia: uma revisão de literaturaHyperalphalipoproteinemia: a literature reviewHiperalfalipoproteinemia: una revisión de la literaturaHiperalfalipoproteínaHDLCETPSR-BI.HyperalphalipoproteinHDLCETPSR-BI.HiperalfalipoproteínaHDLCETPSR-BI. Objective: To analyze and address the causes and alterations related to hyperalphalipoproteinemia, comparing the general patterns of the population. Methodology: An Integrative Literature Review was conducted, in which key words specified in the Pubmed and Science Direct databases were used: "hyperalphalipoprotenemia" OUR "hyperalphalipoprotein" OUR "HDLc". Results: Mutations in individuals with hyperalphalipoproteinemia, single nucleotide polymorphisms, deleterious genes, cetp gene, hepatic SR-BI, endothelial lipase (EL) gene, splicing defect, genes and proteins ANGPTL3 and ANGPTL8 can be highlighted. In addition, changes in surface fluidity and HDLc membrane constituents were noted, changes in the RCT process and in the ability to increase expression and to activate endothelial synthesis of nitric oxide (NO). Furthermore, changes caused by CETP deficiency cannot be related to a cardioprotective, antiatherogenic and anti-inflammatory effect, and even a U-shaped relationship between plasma HDLc and ischemic electrocardiographic changes, where CETP deficiency accumulates. Moreover, the presence of the P376L variant, intervenenegatively in the processing of SR-BI. Finally, individuals with higher HDLc levels exhibit cholesterol particles enriched by apolipoproteins, which cause changes to the anti-inflammatory action of HDL itself. Conclusion: Changes in the physiological functioning of HDLc, which cause hyperalphalipoproteinemia, are caused by several mutations that lead to changes in the membrane mechanism, CETP, SR-BI and inflammatory processes. More research is needed to conclude about the cardioprotective effect.Objetivo: Analisar e abordar as causas e as alterações relacionadas à hiperalfalipoproteinemia, tendo como comparação os padrões gerais da população. Metodologia: Realizou-se uma Revisão de Literatura Integrativa, na qual utilizou palavras chaves especificadas nas bases de dados Pubmed e Science Direct: “hyperalphalipoprotenemia” OUR “hyperalphalipoprotein” OUR “HDLc”. Resultados: Pode-se destacar as mutações em indivíduos com hiperalfalipoproteinemia os polimorfismos de nucleotídeo único, genes deletérios, gene que expressa o CETP, deleção de SR-BI hepático, gene da lipase endotelial (EL), defeito de splicing, genes e proteínas ANGPTL3 e ANGPTL8. Além disso, foram notadas alterações na fluidez superficial e constituintes da membrana do HDLc, alteração no processo de RCT e na capacidade de aumentar a expressão e por ativar a síntese endotelial do óxido nítrico (NO). Ademais, as alterações causadas por deficiência na CETP não podem ser relacionadas a um efeito cardioprotetor, antiaterogênico e anti inflamatório, sendo até encontrada uma relação em forma de U entre o HDLc plasmático e as alterações eletrocardiográficas isquêmicas, onde a deficiência de CETP se acumula. Outrossim, presença da variante P376L, intervêm negativamente no processamento de SR-BI. Por fim, indivíduos que apresentam níveis mais elevados HDLc, exibem partículas de colesterol enriquecidas por apolipoproteínas, as quais acarretam alterações a ação anti-inflamatória do próprio HDL. Conclusão: Alterações no funcionamento fisiológico do HDLc, que provocam a hiperalfalipoproteinemia, são causadas por diversas mutações que levam a alterações no mecanismo de membrana, CETP, SR-BI e processos inflamatórios. Faz-se necessárias mais pesquisas para concluir a respeito do efeito cardioprotetor.Objetivo: Analizar y abordar las causas y alteraciones relacionadas con la hiperalfalipoproteinemia, comparando los patrones generales de la población. Metodología: Se realizó una Revisión Integrativa de la Literatura, utilizando palabras clave especificadas en las bases de datos Pubmed y Science Direct: “hyperalphalipoprotenemia” OUR “hyperalphalipoprotein” OUR “HDLc”. Resultados: Se destacan mutaciones en individuos con hiperalfalipoproteinemia: polimorfismos de un solo nucleótido, genes deletéreos, gen que expresa CETP, deleción hepática SR-BI, gen de la lipasa endotelial (EL), defecto de splicing, genes y proteínas ANGPTL3 y ANGPTL8. Además, se observaron alteraciones en la fluidez superficial y constituyentes de membrana de HDLc, alteración en el proceso RCT y en la capacidad de aumentar la expresión y activar la síntesis endotelial de óxido nítrico (NO). Además, los cambios provocados por el déficit de CETP no pueden relacionarse con un efecto cardioprotector, antiaterogénico y antiinflamatorio, e incluso se ha encontrado una relación en forma de U entre el cHDL plasmático y los cambios electrocardiográficos isquémicos, donde se acumula el déficit de CETP. Además, la presencia de la variante P376L interfiere negativamente en el procesamiento de SR-BI. Finalmente, los individuos con niveles más altos de HDLc presentan partículas de colesterol enriquecidas en apolipoproteínas, que alteran la acción antiinflamatoria de las propias HDL. Conclusión: Los cambios en el funcionamiento fisiológico de HDLc, que causan hiperalfalipoproteinemia, son causados por varias mutaciones que conducen a cambios en el mecanismo de membrana, CETP, SR-BI y procesos inflamatorios. Se necesita más investigación para concluir sobre el efecto cardioprotector.Research, Society and Development2022-11-25info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/3746110.33448/rsd-v11i15.37461Research, Society and Development; Vol. 11 No. 15; e525111537461Research, Society and Development; Vol. 11 Núm. 15; e525111537461Research, Society and Development; v. 11 n. 15; e5251115374612525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/37461/31256Copyright (c) 2022 Paula Rayssa Rodrigues; Lucas Martins; Alessandra Cristina Pupin Silvériohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessRodrigues, Paula Rayssa Martins, Lucas Silvério, Alessandra Cristina Pupin2022-11-27T19:56:23Zoai:ojs.pkp.sfu.ca:article/37461Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:51:37.544204Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Hiperalfalipoproteinemia: uma revisão de literatura
Hyperalphalipoproteinemia: a literature review
Hiperalfalipoproteinemia: una revisión de la literatura
title Hiperalfalipoproteinemia: uma revisão de literatura
spellingShingle Hiperalfalipoproteinemia: uma revisão de literatura
Rodrigues, Paula Rayssa
Hiperalfalipoproteína
HDL
CETP
SR-BI.
Hyperalphalipoprotein
HDL
CETP
SR-BI.
Hiperalfalipoproteína
HDL
CETP
SR-BI.
title_short Hiperalfalipoproteinemia: uma revisão de literatura
title_full Hiperalfalipoproteinemia: uma revisão de literatura
title_fullStr Hiperalfalipoproteinemia: uma revisão de literatura
title_full_unstemmed Hiperalfalipoproteinemia: uma revisão de literatura
title_sort Hiperalfalipoproteinemia: uma revisão de literatura
author Rodrigues, Paula Rayssa
author_facet Rodrigues, Paula Rayssa
Martins, Lucas
Silvério, Alessandra Cristina Pupin
author_role author
author2 Martins, Lucas
Silvério, Alessandra Cristina Pupin
author2_role author
author
dc.contributor.author.fl_str_mv Rodrigues, Paula Rayssa
Martins, Lucas
Silvério, Alessandra Cristina Pupin
dc.subject.por.fl_str_mv Hiperalfalipoproteína
HDL
CETP
SR-BI.
Hyperalphalipoprotein
HDL
CETP
SR-BI.
Hiperalfalipoproteína
HDL
CETP
SR-BI.
topic Hiperalfalipoproteína
HDL
CETP
SR-BI.
Hyperalphalipoprotein
HDL
CETP
SR-BI.
Hiperalfalipoproteína
HDL
CETP
SR-BI.
description Objective: To analyze and address the causes and alterations related to hyperalphalipoproteinemia, comparing the general patterns of the population. Methodology: An Integrative Literature Review was conducted, in which key words specified in the Pubmed and Science Direct databases were used: "hyperalphalipoprotenemia" OUR "hyperalphalipoprotein" OUR "HDLc". Results: Mutations in individuals with hyperalphalipoproteinemia, single nucleotide polymorphisms, deleterious genes, cetp gene, hepatic SR-BI, endothelial lipase (EL) gene, splicing defect, genes and proteins ANGPTL3 and ANGPTL8 can be highlighted. In addition, changes in surface fluidity and HDLc membrane constituents were noted, changes in the RCT process and in the ability to increase expression and to activate endothelial synthesis of nitric oxide (NO). Furthermore, changes caused by CETP deficiency cannot be related to a cardioprotective, antiatherogenic and anti-inflammatory effect, and even a U-shaped relationship between plasma HDLc and ischemic electrocardiographic changes, where CETP deficiency accumulates. Moreover, the presence of the P376L variant, intervenenegatively in the processing of SR-BI. Finally, individuals with higher HDLc levels exhibit cholesterol particles enriched by apolipoproteins, which cause changes to the anti-inflammatory action of HDL itself. Conclusion: Changes in the physiological functioning of HDLc, which cause hyperalphalipoproteinemia, are caused by several mutations that lead to changes in the membrane mechanism, CETP, SR-BI and inflammatory processes. More research is needed to conclude about the cardioprotective effect.
publishDate 2022
dc.date.none.fl_str_mv 2022-11-25
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/37461
10.33448/rsd-v11i15.37461
url https://rsdjournal.org/index.php/rsd/article/view/37461
identifier_str_mv 10.33448/rsd-v11i15.37461
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/37461/31256
dc.rights.driver.fl_str_mv Copyright (c) 2022 Paula Rayssa Rodrigues; Lucas Martins; Alessandra Cristina Pupin Silvério
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Paula Rayssa Rodrigues; Lucas Martins; Alessandra Cristina Pupin Silvério
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 15; e525111537461
Research, Society and Development; Vol. 11 Núm. 15; e525111537461
Research, Society and Development; v. 11 n. 15; e525111537461
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052828030599168